Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide

Model NO.
Dsung-Rebamipide
Mf
C19h15cln2o4
MW
370.7864
CAS No.
90098-04-7
Shelf Life
2 Years
Boiling Point
695 C at 760 Mmhg
Refractive Index
1.634
Melting Point
290 C(DEC.)(Lit.)
Density
1.394
Application
Pharmaceutical Raw Material
Assay
HPLC 99%
Test Method
HPLC
Specific
COA
Product Name
Rebamipide
Grade
Pharmaceutical Grade
Transport Package
Negotiable
Specification
99%
Trademark
D-Sung
Origin
Shaanxi
Production Capacity
2 Ton/Month
Reference Price
$ 270.00 - 360.00
Contact Us

Product Description

Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide
Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide
 
Product Description

Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide

Product Details

Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide

Product Name Rebamipide
Appearance Off-white crystalline powder
CAS No. 90098-04-7
MF C19H15ClN2O4
MW 370.7864
Rebamipide  an amino acid derivative of 2-(1H)-quinolinone, is used for mucosal protection, healing of gastroduodenal ulcers, and treatment of gastritis.  It works by enhancing mucosal defense, scavenging free radicals, and temporarily activating genes encoding cyclooxygenase-2.
Application & Function

Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide (1) Prevention and treatment of gastric mucosal damage caused by NSAIDs Rebamipide has a significant reversal of the side effects such as decreased gastric mucosal prostaglandin production and increased mucosal permeability caused by NSAIDs.  Moreover, studies have found that patients taking NSAIDs have high expression of HIF-1 in the epithelial gastric mucosa, indicating that the gastric mucosa is in a hypoxic-ischemic state;  while patients taking rebamipide have significantly lower HIF-1, indicating that rebamipide is taking NSAIDs The gastric mucosa of the patient has a good protective effect.  From this point of view, rebamipide may have a preventive and therapeutic effect on gastric mucosal damage caused by NSAIDs (especially non-selective NSAIDs) drugs.

(3) Other studies have reported that the body temperature of gastric cancer patients who took rebamipide before surgery was significantly lower than that of the control group, and the serum IL-6 content was also significantly lower than that of the control group, indicating that rebamipide has an effect on gastric cancer.  Systemic inflammatory response syndrome after surgery has a certain improvement effect;  Rebamipide may become a new treatment for ulcerative colitis;  it may become a new and effective treatment for Meniere's disease.

Specification

Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide Purity 99% Rebamipide Intermediate Rebamipide Powder Pharmaceutical Raw Material Rebamipide

 

 

 

Pharmaceutical Intermediate

PNEUTEC.IT, 2023